IP Library › Granted Patent US 7,211,073
Granted Patent B2
US 7,211,073 · App. 10/803,468 · Granted May 1, 2007

Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site

Assignee: Catharos Medical Systems Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,211,073
App. No.
10/803,468
Granted
May 1, 2007
Kind
B2
Abstract

Methods and devices for selectively removing an agent from a physiological efferent fluid collection site are provided. A feature of the invention is that a non-occlusive aspiration device is employed to selectively remove the target agent from the site only when the target agent is present in the site. Also provided are systems and kits for performing the subject methods. The subject invention finds use in a variety of different applications, including the selective removal of both therapeutic and diagnostic agents from a variety of different physiological sites.

Claims (28)

1. A method for removing contrast agent from a physiological efferent fluid collection site of a body, said method comprising:

introducing a non-occlusive aspiration element to a target site at least proximal to said physiological efferent fluid collection site; and

activating said aspiration element when said contrast agent is at least predicted to be present in said target site to selectively remove fluid comprising said contrast agent from said physiological efferent fluid collection site;

wherein said aspiration element does not occlude said target site when activated and said removed fluid is not returned to the body.

2. The method according to claim 1 , wherein said physiological efferent fluid collection site is a vascular fluid collection site.

3. The method according to claim 2 , wherein said vascular fluid collection site is a cardiovascular fluid collection site.

4. The method according to claim 3 , wherein said cardiovascular fluid collection site is a coronary cardiovascular fluid collection site.

5. The method according to claim 4 , wherein said coronary cardiovascular fluid collection site is a coronary sinus.

6. The method according to claim 1 , wherein said physiological efferent fluid collection site is present in a mammal.

7. The method according to claim 6 , wherein said mammal is a human.

8. The method according to claim 1 , wherein said non-occlusive aspiration element comprises a detector for at least predicting the presence of said agent in said physiological efferent fluid collection site, wherein said detector is located at an upstream location of said non-occlusive aspiration element.

9. The method according to claim 8 , wherein said detector is located at the vicinity of said target site.

10. The method according to claim 8 , wherein said detector is a fiber-optic detector.

11. A method for removing an agent from a physiological efferent fluid collection site of a body, said method comprising:

introducing a non-occlusive aspiration element to a target site at least proximal to said physiological efferent fluid collection site, wherein said non-occlusive aspiration element comprises a detector for at least predicting the presence of said agent in said physiological efferent fluid collection site and said detector is located at an upstream location of said non-occlusive aspiration element; and

activating said aspiration element when said agent is at least predicted to be present in said target site to selectively remove fluid comprising said agent from said physiological efferent fluid collection site;

wherein said aspiration element does not occlude said target site when activated and said removed fluid is not returned to the body.

12. The method according to claim 11 , wherein said physiological efferent fluid collection site is a vascular fluid collection site.

13. The method according to claim 12 , wherein said vascular fluid collection site is a cardiovascular fluid collection site.

14. The method according to claim 13 , wherein said cardiovascular fluid collection site is a coronary cardiovascular fluid collection site.

15. The method according to claim 14 , wherein said coronary cardiovascular fluid collection site is a coronary sinus.

16. The method according to claim 11 , wherein said physiological efferent fluid collection site is present in a mammal.

17. The method according to claim 16 , wherein said mammal is a human.

18. The method according to claim 11 , wherein said agent is a therapeutic agent.

19. The method according to claim 11 , wherein said agent is a diagnostic agent.

20. The method according to claim 19 , wherein said diagnostic agent is a contrast agent.

21. The method according to claim 11 , wherein said detector is a fiber-optic detector.

22. The method according to claim 11 , wherein said detector is located at the vicinity of said target site.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2005
From: DYERX MEDICAL, INC.
To: CATHAROS MEDICAL SYSTEMS, INC.
Reel/Frame 016820/0942 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2004
From: COURTNEY, BRIAN K.; HASSAN, ALI; FITZGERALD, PETER J.
To: DYERX MEDICAL, INC.
Reel/Frame 014941/0357 →
Continuity (2)
Provisional Application 6045610700 · Mar 18, 2003
Related Publication 20040254523A1 · Dec 16, 2004